Related Experiment Video
Updated: Feb 10, 2026

Phosphoproteomic Strategy for Profiling Osmotic Stress Signaling in Arabidopsis
Published on: June 25, 2020
A systematic understanding of signaling by ErbB2 in cancer using phosphoproteomics
C Sidhanth1,1, P Manasa1,1, S Krishnapriya1,1
1Laboratory for Cancer Biology, Departments of Medical Oncology and Clinical Research, Cancer Institute (WIA), 38 Sardar Patel Road Guindy, Chennai-600036, India.
Abstract:
ErbB2 is an important receptor tyrosine kinase and a member of the ErbB family. Although it does not have a specific ligand, it transmits signals downstream by heterodimerization with other receptors in the family. It plays a major role in a variety of cellular responses like proliferation, differentiation, and adhesion. ErbB2 is amplified at the DNA level in breast cancer (20%-30%) and gastric cancer (10%-20%), and trastuzumab is effective as a therapeutic antibody. This review is a critical analysis of the currently published data on the signaling pathways of ErbB2 and the interacting proteins. It also focuses on the techniques that are currently available to evaluate the entire phosphoproteome following activation of ErbB2. Identification of new and relevant phosphoproteins can not only serve as new therapeutic targets but also as a surrogate marker in patients to assess the activity of compounds that inhibit ErbB2. Overall, such analysis will improve understanding of signaling by ErbB2.
Insights
This review analyzes ErbB2 signaling pathways and phosphoproteome analysis techniques. Identifying new phosphoproteins can reveal therapeutic targets and markers for ErbB2-inhibiting compounds.
Area of Science:
- Molecular Biology
- Oncology
- Biochemistry
Background:
- ErbB2 is a receptor tyrosine kinase crucial for cellular functions like proliferation.
- ErbB2 amplification is common in breast and gastric cancers, making it a therapeutic target.
- Trastuzumab is an effective therapeutic antibody for ErbB2-amplified cancers.
Purpose of the Study:
- To critically analyze published data on ErbB2 signaling pathways and interacting proteins.
- To review techniques for evaluating the phosphoproteome after ErbB2 activation.
- To highlight the potential of phosphoproteins as therapeutic targets and surrogate markers.
Main Methods:
- Literature review of signaling pathways and protein interactions.
- Analysis of phosphoproteomic evaluation techniques.
- Discussion of therapeutic implications.
Main Results:
- ErbB2 signals downstream via heterodimerization, independent of a specific ligand.
- Phosphoproteomic analysis can identify novel therapeutic targets and markers.
- Understanding ErbB2 signaling is key to developing targeted therapies.
Conclusions:
- Comprehensive analysis of ErbB2 signaling pathways and phosphoproteome is essential.
- New phosphoproteins identified can serve as biomarkers and therapeutic targets.
- Improved understanding of ErbB2 signaling will advance cancer treatment.
More Related Videos
12:23Phosphopeptide Enrichment Coupled with Label-free Quantitative Mass Spectrometry to Investigate the Phosphoproteome in Prostate Cancer
Published on: August 2, 2018
09:28Author Spotlight: Advancing EVtrap for High-Throughput Proteomics in Disease Biomarker Discovery
Published on: October 27, 2023
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Understanding the Self
Random and Systematic Errors
Understanding Self-Concept
Understanding Deception
Systematic Sampling Method
Systematic sampling is one of the simplest methods...